Compliance Rate
Compliance Rate
0.0%
Compliant submissions
0
Incompliant submissions
1
Total trials
1
My Organizations' Clinical Trials
Showing 975 of 1949 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/23/24
End: 12/31/34
Due: 12/31/35
Phase: N/A
Priority: Normal
Start: 02/01/20
End: 02/28/22
Due: 02/28/23
Phase: N/A
Priority: Normal
Start: 03/27/23
End: 12/30/28
Due: 12/30/29
Phase: N/A
Priority: Normal
Start: 05/31/16
End: 02/03/17
Due: 02/03/18
Phase: N/A
Priority: Normal
Start: 06/01/20
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 05/31/14
End: 04/30/15
Due: 04/30/16
Phase: N/A
Priority: Normal
Start: 07/28/10
End: 03/25/23
Due: 03/25/24
Phase: N/A
Priority: Normal
Start: 07/12/17
End: 03/13/18
Due: 03/13/19
PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas
Phase: N/A
Priority: Normal
Start: 10/31/05
End: 06/30/11
Due: 06/30/12
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 09/21/20
Due: 09/21/21
Phase: N/A
Priority: Normal
Start: 11/30/09
End: 11/30/14
Due: 11/30/15
Phase: N/A
Priority: Normal
Start: 10/31/15
End: 03/02/17
Due: 03/02/18
Phase: N/A
Priority: Normal
Start: 09/30/16
End: 05/10/18
Due: 05/10/19
Phase: N/A
Priority: Normal
Start: 02/01/17
End: 03/09/22
Due: 03/09/23
Phase: N/A
Priority: Normal
Start: 04/30/06
End: 06/30/12
Due: 06/30/13
Phase: N/A
Priority: Normal
Start: 08/05/23
End: 06/05/27
Due: 06/05/28
Phase: N/A
Priority: Normal
Start: 11/30/10
End: 04/30/12
Due: 04/30/13
Phase: N/A
Priority: Normal
Start: 10/31/23
End: 12/11/23
Due: 12/11/24
Phase: N/A
Priority: Normal
Start: 12/12/18
End: 06/16/20
Due: 06/16/21
Phase: N/A
Priority: Normal
Start: 06/03/24
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 02/29/16
Due: 02/28/17
Phase: N/A
Priority: Normal
Start: 12/31/08
End: 04/30/11
Due: 04/30/12
Phase: N/A
Priority: Normal
Start: 04/30/13
End: 11/30/15
Due: 11/30/16
Phase: N/A
Priority: Normal
Start: 01/31/05
End: 03/31/07
Due: 03/31/08
Phase: N/A
Priority: Normal
Start: 09/01/22
End: 03/29/24
Due: 03/29/25